BioLineRx Ltd (BLRX) — Cash Flow Reinvestment Rate
BioLineRx Ltd (BLRX) has a Cash Flow Reinvestment Rate of 4.09x as of December 2023, reinvesting $20.41 Million (capex $18.00K plus investments $-20.39 Million) from operating cash flow of $4.99 Million. See cash generation quality of BioLineRx Ltd to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
BioLineRx Ltd Cash Flow Reinvestment Rate (2010–2010)
Historical reinvestment intensity for BioLineRx Ltd across 1 annual periods. For the full cash flow conversion analysis, see BLRX cash flow metrics.
Annual Cash Flow Reinvestment Rate for BioLineRx Ltd (2010–2010)
Year-by-year capital reinvestment analysis for BioLineRx Ltd. See BLRX FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2010 | 0.06x | $660.94K | $11.46 Million | $660.94K | — |